Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
First Hospital of Lanzhou University · Lanzhou University
Abstract
An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan, China; the epidemic is more widespread than initially estimated, with cases now confirmed in multiple countries.
The aim of this meta-analysis was to assess the prevalence of comorbidities in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and the risk of underlying diseases in severe patients compared to non-severe patients.
Citation impact
- FWCI
- 355.11
- Percentile
- 100%
- References
- 29
Authors
10- JYJing Yang
First Hospital of Lanzhou University, Lanzhou University
- YZYa Zheng
First Hospital of Lanzhou University, Lanzhou University
- XGXi Gou
First Hospital of Lanzhou University, Lanzhou University
- KPKe Pu
First Hospital of Lanzhou University, Lanzhou University
- ZCZhaofeng Chen
First Hospital of Lanzhou University, Lanzhou University
Topics & keywords
- Medicine
- Meta-analysis
- Odds ratio
- Internal medicine
- Confidence interval
- Diabetes mellitus
- Comorbidity
- Disease
- Good health and well-being